Комбизим
Комбизим
Authorised
- Tetracycline hydrochloride
- NEOMYCIN SULFATE
- Prednisolone acetate
- Chymotrypsin
- Trypsin
- Papain
Product identification
Medicine name:
Комбизим
Active substance:
- Tetracycline hydrochloride
- NEOMYCIN SULFATE
- Prednisolone acetate
- Chymotrypsin
- Trypsin
- Papain
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
-
External use
Product details
Active substance and strength:
-
Tetracycline hydrochloride30.00/milligram(s)1.00millilitre(s)
-
NEOMYCIN SULFATE22.50/milligram(s)1.00millilitre(s)
-
Prednisolone acetate2.00/milligram(s)1.00millilitre(s)
-
Chymotrypsin0.40/milligram(s)1.00millilitre(s)
-
Trypsin0.40/milligram(s)1.00millilitre(s)
-
Papain1.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD03BA
- QD07CA03
- QJ01AA20
- QJ01GB05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Package description:
- Available only in Bulgarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2224
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 16/05/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 24/11/2022